Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.35 BATS BZX Real-Time Price As of 11:22am ET |  +0.025 / +1.89%Today’s Change | 0.40 Today|||52-Week Range 2.10 | +78.50% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 62.6M | 85.4M | 60.8M | 74.6M | |
| Short Term Investment Cash | 39.8M | 22.8M | -24.6M | 13.7M | ||
| Cash & Short Term Investments | 107.5M | 104.6M | 75.3M | 74.6M | ||
| Receivables | Receivables | 0.00 | 0.00 | 321.0K | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 704.0K | 779.0K | 2.0M | 2.6M | |
| Current Assets | 108.2M | 105.4M | 77.7M | 77.1M | ||
| Total Assets | Property, Plant and Equipment - Gross | 2.3M | 2.7M | 3.1M | 3.3M | |
| Depreciation | -637.0K | -1.4M | -2.0M | -2.5M | ||
| Other Assets | 72.0K | 190.0K | 321.0K | 1.3M | ||
| Total Assets | 110.0M | 107.0M | 79.0M | 79.1M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 0.00 | 2.8M | |
| Short Term Debt | 0.00 | 0.00 | 2.7M | 9.9M | ||
| Accrued Expenses | 1.4M | 3.3M | 4.3M | 3.9M | ||
| Other Current Liabilities | 4.5M | 6.2M | 6.8M | 4.3M | ||
| Other Liabilities | 6.0M | 8.9M | 12.1M | 19.9M | ||
| Total Liabilities | Long Term Debt | 0.00 | 9.8M | 7.2M | 0.00 | |
| Other Liabilities | 88.0K | 80.0K | 0.00 | 81.0K | ||
| Total Liabilities | 6.1M | 18.8M | 19.3M | 20.0M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 103.9M | 88.2M | 59.7M | 59.1M | ||
| Total Shareholder Equity | 103.9M | 88.2M | 59.7M | 59.1M | ||
| Share Information | Common Shares Outstanding | 13.8M | 16.8M | 20.5M | 27.8M | |
| Addtl. Info. | No data currently available for this section. | |||||
